BackDeep Medicine Acquisition - Units (1 Ord Share Class A , 1Right) Overview

Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right) Total Current Liabilities

Latest total current liabilities for DMAQU: $16M.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$15.66M
13.99% YoYΔ $-2.55M vs prior year quarter

Peer average

Loading

Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right) Total Current Liabilities History

Loading

Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right) vs. peers: Total Current Liabilities Comparison

Loading

Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right) Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right) (DMAQU) FAQ

The latest total current liabilities for DMAQU is $16M as of March 2026. That compares with $18M in the prior-year period — down 14.0% year over year. Investors often review this figure alongside Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, DMAQU's total current liabilities moved from $18M to $16M — a 14.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Deep Medicine Acquisition - Units (1 Ord Share Class A , 1Right)'s operating scale or balance-sheet position.

A total current liabilities figure of $16M for DMAQU is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting DMAQU's total current liabilities ($16M), review year-over-year change from $18M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.